MARKET

PDSB

PDSB

Pds Biotechnology Corporation
NASDAQ
0.6452
-0.0152
-2.30%
Opening 09:51 03/06 EST
OPEN
0.6500
PREV CLOSE
0.6604
HIGH
0.6529
LOW
0.6400
VOLUME
30.65K
TURNOVER
--
52 WEEK HIGH
1.915
52 WEEK LOW
0.6012
MARKET CAP
33.79M
P/E (TTM)
-0.7875
1D
5D
1M
3M
1Y
5Y
1D
VTI ETF Adds $1B in Net Flows — Daily Snapshot, 3/6/26
TipRanks · 1h ago
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—3/5/26
TipRanks · 1d ago
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—3/4/26
TipRanks · 2d ago
PDS Biotechnology Receives Nasdaq Noncompliance Notice, Gets Time Through Aug. 24 To Regain Compliance
Benzinga · 2d ago
Nasdaq flags PDS Biotechnology for sub-$1 minimum bid price deficiency
Reuters · 2d ago
Why Is the VTI ETF Down Today? Daily Snapshot – 3/3/26
TipRanks · 3d ago
VOO vs. VTI: Which Vanguard ETF Is the Smarter Buy for 2026?
TipRanks · 3d ago
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—3/2/26
TipRanks · 4d ago
More
About PDSB
PDS Biotechnology Corporation is a clinical-stage immunotherapy company. The Company is developing a pipeline of targeted cancer immunotherapies based on its Versamune T cell-activator and Versamune in combination with its interleukin 12 (IL-12) fused antibody drug conjugate (ADC), PDS01ADC, a tumor targeting immunocytokine. PDS0101 is its lead Versamune based immunotherapy. PDS0101 combines Versamune with a mixture of short proteins (peptides) derived from the cancer-causing HPV16 viral protein. Versamune is a proprietary lipid nanoparticle and T cell activating platform. PDS0301 is an investigational tumor-targeting antibody conjugate of Interleukin 12 (IL-12) that enhances the proliferation, potency, infiltration, and longevity of T cells in the tumor microenvironment. Its Versamune immunotherapies and Versamune in combination with PDS01ADC, are utilized for treatments in oncology, and Infectimune is utilized for preventive vaccines against infectious agents.

Webull offers PDS Biotechnology Corp stock information, including NASDAQ: PDSB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PDSB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PDSB stock methods without spending real money on the virtual paper trading platform.